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OBJECTIVES: The onset of chronic subdural hematoma may be associated with direct or indirect minor injuries
to the head or a poorly repaired vascular injury. Endothelial progenitor cells happen to be one of the key
factors involved in hemostasis and vascular repair. This study was designed to observe the levels of endothelial
progenitor cells, white blood cells, platelets, and other indicators in the peripheral blood of patients diagnosed
with chronic subdural hematoma to determine the possible relationship between the endothelial progenitor
cells and the occurrence, development, and outcomes of chronic subdural hematoma.
METHOD: We enrolled 30 patients with diagnosed chronic subdural hematoma by computer tomography
scanning and operating procedure at Tianjin Medical University General Hospital from July 2009 to July 2011.
Meanwhile, we collected 30 cases of peripheral blood samples from healthy volunteers over the age of 50.
Approximately 2 ml of blood was taken from veins of the elbow to test the peripheral blood routine and
coagulation function. The content of endothelial progenitor cells in peripheral blood mononuclear cells was
determined by flow cytometry.
RESULTS: The level of endothelial progenitor cells in peripheral blood was significantly lower in preoperational
patients with chronic subdural hematomas than in controls. There were no significant differences between the
two groups regarding the blood routine and coagulation function. However, the levels of circulating
endothelial progenitor cells were significantly different between the recurrent group and the non-recurrent
group.
CONCLUSIONS: The level of circulating endothelial progenitor cells in chronic subdural hematoma patients was
significantly lower than the level in healthy controls. Meanwhile, the level of endothelial progenitor cells in
recurrent patients was significantly lower than the level in patients without recurrence. Endothelial progenitor
cells may be related to the occurrence and recurrence of chronic subdural hematoma.
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& INTRODUCTION
Chronic subdural hematomas (CSDHs) are common
neurosurgical occurrences in intracranial hematoma, with
an incidence ranging from 1-13.1%. Their mortality amounts
to 1.5%,8%, and the recurrence rate is 9.2%-26.5% (1-6). The
pathogenesis of CSDH remains hypothetical. There has been
significant discussion and debate regarding the complex
pathogenesis of CSDH, particularly in terms of the
inflammatory process (7), the head trauma etiology (8,9),
the osmotic gradient theory (10-12), and recurrent hemor-
rhage associated with hyperfibrinolysis (13).
The onset of CSDH may be associated with direct or
indirect minor injury of the head or poor vascular repair.
Accordingly, there are a large number of brittle neovascular
capillaries in the outer membrane of the resulting hematoma,
and continuous leaking from these structural capillary defects
is the main reason for the development of CSDH. The outer
membrane of the hematoma capsule generally contains
numerous fragile macrocapillaries (also called sinusoidal
vessels) with vascular lumina (14). When viewed with an
electron microscope, these lumina are often extremely wide
($ 40 mm in diameter), contain several blood cells and consist
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of loose junctions between adjacent endothelial cells and a
partial absence of the basement membrane and pericytes (15).
Endothelial progenitor cells (EPCs) happen to be one of
the key factors involved in hemostasis and vascular repair.
These cells, through the secretion of related cytokines, play
an extremely important role in the repair and regeneration
of damaged blood vessels. Therefore, we observed the levels
of EPCs, white blood cells, platelets, and other indicators in
the peripheral blood of CSDH patients to determine the
possible relationship between EPCs and the occurrence,
development, and outcomes of CSDH.
& MATERIALS AND METHODS
Patients
We collected clinical information from 30 patients who
were diagnosed with CSDH by computer tomography (CT)
scanning and operating procedures at Tianjin Medical
University General Hospital from July 2009 to July 2011.
Sixteen patients had clear histories of minor head trauma in
the last year before they were diagnosed with CSDH. All
patients underwent a single burr-hole drainage surgery
under local anesthesia. Four cases relapsed and recovered
after reoperation. We collected peripheral blood samples 2
hours prior to the surgery and 14 days after the surgery.
Meanwhile, over the same period, we collected peripheral
blood samples from 30 healthy volunteers over the age of 50.
Head CT scans were performed at Tianjin Medical
University General Hospital in the Division of Radiology.
Patients who had diabetes (16), dyslipidemia, intractable
hypertension coronary heart disease, kidney disease (17), or
hemorrhage disease (18) were classified as exclusions. No
estrogen or anticoagulant agents were used in either group
due to their potential influence on EPC levels (19,20).
Laboratory management
We took approximately 2 ml of blood from the veins of
the elbow, immediately placed it in EDTA-K2 anticoagula-
tion tubes, and gently mixed it upside down to prevent
platelet adhesion and aggregation. Peripheral blood routine
and coagulation function were tested by Tianjin Medical
University General Hospital, Department of Clinical
Laboratory (automatic biochemistry analyzer: SYSMEX
XE-2100, Sysmex Corporation, Japan).
Because EPCs are characterized by the co-expression of
the hematopoietic stem cell/progenitor markers CD34 and
CD133 (21,22), we determined the content of EPCs in
peripheral blood mononuclear cells (PBMNCs) by flow
cytometry using dual staining with fluorescein-conjugated
monoclonal antibodies against CD34/CD133 markers.
PBMNCs were isolated by density centrifugation according
to the manufacturers’ instructions. We incubated 106
PBMNCs with PE-labeled monoclonal mouse anti-human
CD34 (BD Biosciences, USA) and FITC-labeled monoclonal
mouse anti-human CD133 (BD Biosciences, USA) antibodies
for 30 minutes at 4 C˚, according to the manufacturers’
instructions. At least 100,000 events were acquired in the
lymphomonocytic gate using a FACSCalibur cytometer (BD
FACS Aris, USA). The number of progenitor cells was
expressed as a percentage of all lymphomonocytic cells.
Statistics
Chi-square tests or Student’s T tests were used to
compare categorical and continuous variables among the
groups. Experimental data are presented as means ¡ SD.
Statistical analyses were performed using commercially
available software (SPSS, ver. 18.0, SPSS Inc., Chicago, IL),
and a p-value of ,0.05 was deemed to indicate statistical
significance.
Ethics
The study was approved by the Tianjin Medical
University General Hospital ethical standards committee
on human experimentation. Written informed consent was
also obtained from both patients and control participants.
& RESULTS
In this study, we first evaluated the EPC levels in CSDH
patients treated with burr-hole drainage surgery and their
association with blood routine and coagulation function.
The CT scan performance of CSDH is a lunula or crescent-
shaped lower-density area under the skull plate on one or
both sides. High- or hybrid-density shadows occurred when
the hematoma volume was large, slowly absorbed, or
bleeding recurrently. The demographic characteristics of
the patient and control groups are summarized (Table 1).
The patients ranged in age from 45 to 82 years (average
60.8¡14.4 years, means¡SD). There were 22 men and 8
women. All of the CSDH cases underwent burr-hole
surgery. All hematoma removal cases were irrigated with
saline solution in the subdural space. The control group
ranged in age from 52 to 75 years (average 64.2¡8.5 years,
means¡SD). There were 16 men and 14 women. No
significant differences in age and gender between the
CSDH and control groups were identified.
The average number of circulating EPCs in preoperational
CSDH patients was 43.43¡11.87 per 26105 mononuclear
cells. The average number of circulating EPCs in the health
control group was 64.62¡15.32 per 26105 mononuclear
cells. The EPC levels in the peripheral blood were
significantly lower in preoperational CSDH patients than
in controls (p = 0.013). Compared with the control group, the
numbers of EPCs in males, premenopausal females, and
postmenopausal females of the CSDH group differed
significantly (p,0.05). Within the CSDH or control groups,
the number of EPCs in premenopausal females was higher
than in the male group or in the postmenopausal female
group (p,0.05). Meanwhile, there was no difference
between the male group and the postmenopausal female
group. There were no significant differences between the
CSDH group and the control group or between males and
females within the same group regarding any indices of
blood routine and coagulation, such as red blood cell (RBC),
white blood cell (WBC), platelet (PLT), and hemoglobin
(Hb) levels; prothrombin time (PT); prothrombin time-
international normalized ratio (PT-INR); activated partial
thromboplastin time (APTT); and thrombin time (TT)
(Table 1).
Six of the 30 CSDH patients suffered recurrences after the
burr-hole drainage operation, and all of them underwent
the surgical treatment again, achieving good recovery. The
change in the average level of circulating EPCs in the six
recurrent patients was 8.54¡5.25 per 26105 mononuclear
cells between postoperation and preoperation. The same
index in the other nonrecurring patients was 35.52¡18.59
per 26105 mononuclear cells. The difference was significant
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between the recurrent group and the non-recurrent group
(p = 0.008) (Table 2).
& DISCUSSION
In recent years, EPCs, especially in the peripheral blood,
have become the focus of research in the field of related
blood vessels. EPCs are immature hematopoietic cells
circulating in the peripheral blood that are capable of
differentiating into mature endothelial cells, thus aiding
in endothelial recovery (23). Small numbers of EPCs are
circulating in the peripheral blood of every healthy adult,
approximately 70-210/ml, accounting for 0.002% of
PBMNCs (24). EPCs are involved not only in the formation
of new blood vessels but also in the maintenance of the
dynamic integrity of vascular membrane; thus, they play an
important role in physiological repair. EPCs participate in
these processes through mobilization, tendency, adhesion,
proliferation, and differentiation. Any pathological and
physiological factors resulting in reduced numbers of
EPCs and fewer dysfunctions may lead to structural and
functional abnormalities during neovascularization.
Structural integrity and functional abnormalities during
neovascularization lead to extravasation of the blood,
increasing the likelihood of bleeding. Currently, it is
generally accepted that the adventitial neovascularization
of hematomas and re-bleeding are key factors in the onset
and development of CSDH (25). Thus, EPC reduction may
be relevant to CSDH.
CSDH mainly occurs in the elderly. The incidence rate in
the population over 65 years of age is 7-13/10 million, and
the rate in people over 70 years of age is 17-58/10 million
(26). However, the CSDH incidence in the general popula-
tion is only approximately 1-3/10 million (26,27). Aging can
lead to a reduction in the number of EPCs in circulation and
a weakening of their function (28-30). Thus, we can infer
that there are both lower numbers of EPCs and related
dysfunction in the peripheral blood of CSDH patients. In
this study, we measured the peripheral blood levels of EPCs
in 30 CSDH patients and in 30 healthy controls. The results
showed that the level of peripheral blood EPCs in CSDH
patients was significantly lower compared to the control
group. Meanwhile, we found that the change in the levels of
EPCs in recurrent patients between postoperation and
preoperation was significantly lower than the level in non-
recurrent patients. These data indicate that a higher
consumption of EPCs in CSDH patients and decreased
EPC levels may lead to a reduced capacity to repair the
endothelium, increasing the risks associated with the
occurrence and recurrence of CSDH. Thus, we propose that
a pharmacological means of increasing the number of
circulating EPCs could help to reduce the recurrence rate
of CSDH.
Through in-depth research on angiogenesis mechanisms
and EPCs, we can be sure that EPCs are not only involved in
the formation of new blood vessels but that they also play
an important role in maintaining the dynamic integrity of
the vascular intima. Any factors leading to a reduction in
the number of EPCs may result in structural and func-
tional abnormalities in the neovascularization process.
Throughout our study, the levels of EPCs in the peripheral
blood of patients with CSDH were significantly lower
compared to the control group, and the levels of peripheral
EPCs in the patients with postoperative recurrence were
Table 1 - Laboratory characteristics of patients and controls.
CSDH Patients (n = 30) Controls (n = 30)
Age 60.8¡14.4 64.2¡8.5
Gender Male Female Male Female
Premenopausal Postmenopausal Premenopausal Postmenopausal
22 3 5 16 5 9
Number of EPCs 37.74¡10.47a 62.28¡10.49a.b.c 38.12¡10.37a 52.58¡14.24 70.47¡9.37b.c 53.18¡16.38
Preoperation (/2*105 MNC) 43.43¡11.87a 64.62¡15.32
Blood Routine
RBC (61012) 4.63¡0.45 3.85¡0.53 4.71¡0.64 3.92¡0.43
WBC (6109) 8.52¡2.62 8.36¡2.41 7.93¡1.12 7.61¡1.03
PLT (6109) 236.24¡71.45 226¡82.49 251.45¡46.39 255.93¡55.29
Hb (6109) 134.28¡17.23 123.46¡18.38 128.46¡16.24 121.35¡18.34
Blood Coagulation
PT (sec) 11.58¡0.41 11.01¡0.62 11.46¡0.53 11.02¡0.42
PT-INR 0.962¡0.031 0.931¡0.025 0.960¡0.031 0.943¡0.027
APTT (sec) 29.63¡6.39 27.38¡5.47 32.29¡4.63 29.48¡4.92
TT (sec) 15.95¡2.62 16.21¡2.95 17.28¡1.61 15.96¡2.41
Values are means ¡ SD. CSDH= chronic subdural hematoma; EPCs = endothelial progenitor cells; MNC=mononuclear cell; RBC= red blood cell;
WBC=white blood cell; PLT =platelet; Hb=hemoglobin; PT=prothrombin time; PT-INR=prothrombin time-international normalized ratio;
APTT =activated partial thromboplastin time; TT = thrombin time.
*T tests were used to compare continuous variables among groups if the data followed a normal distribution; otherwise, nonparametric tests were used.
Chi-square tests were used to compare categorical variables among the groups. a: Compared to the control group, p,0.05; b: Compared to males in the
same group, p,0.05; c: Compared to postmenopausal women in the same group, p,0.05.
Table 2 - Number of EPCs 14 days after operation.
Recurrence No recurrence p-value*
Number of CSDH Patients 6 24 NS
Number of EPCs (/2*105 MNC) 8.54¡5.25a 35.52¡18.59 0.008
Values are means ¡ SD. CSDH= chronic subdural hematoma;
EPCs = endothelial progenitor cells; *T tests were used to compare
continuous variables among groups if the data followed a normal
distribution; otherwise, nonparametric tests were used. Chi-square tests
were used to compare categorical variables among groups. aCompared to
no recurrence, p,0.05. NS=non-significant.
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significantly lower than in patients who did not relapse.
Therefore, we believe that the occurrence and development
of CSDH may be involved in numerous aspects of the
reduction in the number of EPCs in the peripheral blood. At
the very least, this reduction plays an integral role in many
factors. Thus, we put forward the following hypothesis.
When trauma causes a split in the dural border cell layer to
form a substantial subdural hematoma, cerebrospinal fluid
(CSF) and/or blood accumulates as foreign matter, stimu-
lating the inflammatory response and resulting in the
secretion of inflammatory cytokines (31-34), vascular
endothelial growth factor (VEGF) (35), and angiopoietins
(36,37). Similar to granulation tissue, the purpose of new
blood capillaries and the outer membrane is to wrap and
absorb local foreign bodies and to promote healing.
If the number of circulating EPCs is reduced and/or bone
marrow-derived EPCs cannot replenish their consumption,
capillary structural defects will occur. At the same time, in
the case of abnormal cerebral pulsations causing new
damage to the capillaries, both the maintenance of the
intimal integrity and physiological repairs cannot be
completed. With these internal circles, the continuous
resulting effusion from pathologically permeable capillary
walls into the subdural space leads to the formation of a
CSDH and its eventual expansion.
In this study, we conclude that the level of circulating
EPCs in CSDH patients was significantly lower than the
level in healthy controls. Additionally, the level of EPCs in
recurrent patients was significantly lower than the level in
patients without recurrence. Thus, we speculate that the low
level of EPCs may be responsible for the occurrence of
CSDH; furthermore, the continuing low level of EPCs may
be associated with the recurrence of CSDH.
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